
Sientra
#8667
Rank
$2.08M
Marketcap
United States
Country

Mr. Ronald Menezes (Pres, CEO & Director)
Mr. Andrew C. Schmidt (Sr. VP, Treasurer & CFO)
Mr. Oliver Christian Bennett (Sr. VP, Gen. Counsel & Chief Compliance Officer)
Summary
History
Sientra, Inc. develops, manufactures, and markets medical aesthetics products to plastic surgeons. The company initially secured the exclusive licence to the IDEAL IMPLANT, a structured implant, and marketed its product throughout the United States. It then established an FDA-approved facility in Carpinteria, California to manufacture the IDEAL IMPLANT. The next leap in the company's growth was the acquisition of Eurosil, S.A., a Portuguese-based silicone gel implant company. In 2012, it became the first publicly traded breast implant company in the United States, driving its profile and growth. The company continues to manufacture, distribute, and market its products to plastic surgeons in the United States, Australia, and New Zealand.
Mission
Vision
Key Team
Mr. Keith J. Sullivan (Director & Advisor to MiraDry Bus.)
Ms. Caroline F. Van Hove (Exec. Chair of Board of Directors)
Dr. Denise Dajles (SVP of R&D, Regulatory & Quality)
Mr. Jeffrey S. Jones (VP of Operations)
Mr. Matt Hostetler (Chief People Officer)
Ms. Lisa Rosas (Sr. VP of Marketing)
Recognition and Awards
References
Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Mr. Ronald Menezes (Pres, CEO & Director)
Mr. Andrew C. Schmidt (Sr. VP, Treasurer & CFO)
Mr. Oliver Christian Bennett (Sr. VP, Gen. Counsel & Chief Compliance Officer)
